These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37328334)

  • 1. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    Clin Breast Cancer; 2023 Aug; 23(6):598-619. PubMed ID: 37328334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    J Cancer Surviv; 2024 Jun; 18(3):917-927. PubMed ID: 36753003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
    Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
    J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
    Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
    Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 7. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
    Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
    Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
    LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
    J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
    [No Abstract]   [Full Text] [Related]  

  • 10. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
    Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
    J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in diabetes care among incident breast, prostate, and colorectal cancer survivors: a SEER Medicare study.
    Pinheiro LC; Soroka O; Kern LM; Higgason N; Leonard JP; Safford MM
    J Cancer Surviv; 2022 Feb; 16(1):52-60. PubMed ID: 33661509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    J Cancer Surviv; 2023 Aug; 17(4):917-950. PubMed ID: 36369622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity burden and guideline-concordant care for breast cancer.
    Kimmick G; Fleming ST; Sabatino SA; Wu XC; Hwang W; Wilson JF; Lund MJ; Cress R; Anderson RT;
    J Am Geriatr Soc; 2014 Mar; 62(3):482-8. PubMed ID: 24512124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis.
    Vyas A; Gabriel M; Kurian S
    Breast Cancer (Dove Med Press); 2021; 13():259-269. PubMed ID: 33880062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.
    Camacho FT; Tan X; Alcalá HE; Shah S; Anderson RT; Balkrishnan R
    Medicine (Baltimore); 2017 Jun; 96(24):e7147. PubMed ID: 28614244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of opioid prescribing among older cancer survivors.
    Salz T; Mishra A; Gennarelli RL; Lipitz-Snyderman A; Moryl N; Tringale KR; Boudreau DM; Kriplani A; Jinna S; Korenstein D
    Cancer; 2022 Feb; 128(3):570-578. PubMed ID: 34633662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.
    Guy GP; Lipscomb J; Gillespie TW; Goodman M; Richardson LC; Ward KC
    Health Serv Res; 2015 Aug; 50(4):1088-108. PubMed ID: 25491350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and pain interference in two patient cohorts with neuropathic pain: breast cancer survivors and HIV patients.
    Sipilä R; Kemp H; Harno H; Rice ASC; Kalso E
    Scand J Pain; 2021 Jul; 21(3):512-521. PubMed ID: 33725747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
    Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
    Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.